PowerId, UltraShape secure financing

PowerID completes $12 m. fundraising round led by Partech while Yokneam-based UltraShape completes $15.1m. round led by Meritech.

September 6, 2007 17:36


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

PowerID Ltd. said it completed a $12 million fundraising round led by Partech International with the participation of existing shareholders, including Amadeus Capital Partners, Apax Partners, Clal Industries and Investments, and Infinity Venture Capital. PowerID, which was spun off from Power Paper in January, is a leader in field of Battery-Assisted, Passive RFID technology used in areas such as tracking high value pallets with RF-challenging materials from distribution center to customers; industrial paper reels from manufacturer to print house, and metal aircraft parts during the manufacturing process. Separately, Yokneam-based UltraShape, a leader in non-invasive body contouring, said it completed a $15.1m. round of funding led by new investor Meritech Capital Partners. Previous institutional investors Israel seed Partners and Polaris Venture Partners also participated.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection